Anzeige
Mehr »
Samstag, 20.06.2026 - Börsentäglich über 12.000 News
Batterie-Boom: Ein 78-Mio.-CAD-Schwergewicht greift nach Tiefsee-Rohstoffen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
434 Leser
Artikel bewerten:
(2)

Ceva Animal Health appoints Sébastien Huron as Deputy Chief Executive Officer

LIBOURNE, France, April 10, 2026 /PRNewswire/ -- Ceva Animal Health, the world's fifth largest animal health company, majority-owned by its management team, today announces the appointment of Sébastien Huron as Deputy Chief Executive Officer, effective immediately. This move forms part of a broader governance evolution, following Marc Prikazsky's decision to appoint a Deputy CEO and move to a dual leadership structure in which he becomes Executive Chairman, overseeing long term strategic priorities, while Sébastien Huron steers the Group's operational management and chairs the Executive Committee.

Strengthening strategic and operational focus

As Executive Chairman, Marc Prikazsky will concentrate on Ceva's long-term agenda, including strengthening the trusted and longstanding relationships the company maintains with its investors, leading customer focused innovation, developing future leaders, and reinforcing Ceva's role in addressing major global challenges.

Marc Prikazsky commented: "This governance evolution reflects the scale Ceva has reached and our ambition to reinforce both strategic focus and operational excellence. I am delighted to welcome Sébastien, whose experience, global outlook and deeply human leadership will be key assets. I have full confidence in his ability to lead our teams with ambition, courage and pragmatism. Sébastien and I will work closely to ensure continuity while accelerating Ceva's next phase of development."

A global profile and proven leadership

A veterinarian trained at the National Veterinary School of Toulouse, Sébastien Huron began his career in 1994 at Mars Inc. in France, working in marketing for the pet food division. Later that year, he moved to Brazil to join Roussel-Uclaf / Hoechst Roussel Vet, where he spent six years in various leadership roles across marketing, R&D and business development for Latin America and Brazil.

In 2000, he relocated to the United States to join Intervet, first as Director of the Market Development Group for North America, then as Director of the Companion Animals Business Team.

He returned to Europe in 2006, taking responsibility for Southern Europe at Virbac before being appointed Area Director for Europe in 2008. He later joined the Group's Executive Board and became Head of Global Business Operations. From 2017 to 2024, he served as CEO of Virbac, leading the company through a period of record organic growth.

With over 30 years of experience across different continents, Sébastien has developed deep expertise in strategy, marketing, R&D, industrial operations and general management.

He is widely recognized for his collaborative leadership, multicultural vision and strong customer orientation.

Reflecting on his appointment, Sébastien Huron stated:

"I am honored to join Ceva at a moment when the company has an exceptional strategic foundation and a strong culture of innovation. I have always admired the entrepreneurial spirit and passion of Ceva's teams. My priority will be to support them with energy, experience and an entrepreneurial mindset so that, together, we can accelerate the Group's development and continue to deliver meaningful value for our customers and partners worldwide."

About Ceva Animal Health

Ceva Animal Health (Ceva) is the 5th global largest animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers.

With more than 7,200 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: "Together, beyond animal health".

2025 turnover: €1.92 billion

www.ceva.com

Contact:

Emilie Barrail
Group head of external communication
ebarrail@ceva.com

Photo - https://mma.prnewswire.com/media/2953126/Ceva_Animal_Health_1.jpg
Photo - https://mma.prnewswire.com/media/2953127/Ceva_Animal_Health_2.jpg
Logo - https://mma.prnewswire.com/media/2952036/Ceva_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/ceva-animal-health-appoints-sebastien-huron-as-deputy-chief-executive-officer-302738650.html

© 2026 PR Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.